Additionally, the inflammatory profile of endometriosis in this animal model mirrors what has been
reported in human disease [35 - 37] making this an excellent parallel study for our currently reported data.
Not exact matches
research; since most of the
reports have concentrated on justifying the creation of cloned
human embryos for research into and treatment of neurodegenerative
diseases such as Parkinson's, «stem - cells» has become synonymous with «embryonic stem - cells»
in the public imagination.
Bacteria found
in humans, animals and food continue to show resistance to widely used antimicrobials, says the latest
report on antimicrobial resistance (AMR)
in bacteria by the European Food Safety Authority (EFSA) and the European Centre for
Disease Prevention and Control (ECDC).
Former EPA Region 2 Administrator Judith Enck, who was featured
in the Politico article and is also a regular voice on WAMC, called the actions by EPA and the Department of Defense «scientific censorship» of the
report being compiled by the Department of Health and
Human Services» Agency for Toxic Substances and
Disease Registry.
But
in March, Lichun Tang of China's Beijing Proteome Research Center and colleagues
reported using CRISPR / Cas9 to correct
disease - causing mutations
in a small number of viable
human embryos.
A recent study published
in Annals of Neurology
reports that healthy
human tissue grafted to the brains of patients with Huntington's
disease in the hopes of treating the neurological disorder also developed signs of the illness, several years after the graft.
In this latest advance reported in PNAS, the Wyss team showed that the human gut - on - a-chip's unique ability to co-culture intestinal cells with living microbes from the normal gut microbiome for an extended period of time, up to two weeks, could allow breakthrough insights into how the microbial communities that flourish inside our GI tracts contribute to human health and diseas
In this latest advance
reported in PNAS, the Wyss team showed that the human gut - on - a-chip's unique ability to co-culture intestinal cells with living microbes from the normal gut microbiome for an extended period of time, up to two weeks, could allow breakthrough insights into how the microbial communities that flourish inside our GI tracts contribute to human health and diseas
in PNAS, the Wyss team showed that the
human gut - on - a-chip's unique ability to co-culture intestinal cells with living microbes from the normal gut microbiome for an extended period of time, up to two weeks, could allow breakthrough insights into how the microbial communities that flourish inside our GI tracts contribute to
human health and
disease.
•
In other funding news, the National Institutes of Health announced a new $ 17 million program to investigate whether extracellular RNA plays an important signaling role in people, and whether it can be harnessed to diagnose and treat human diseases, Mitch Leslie reports in News & Analysi
In other funding news, the National Institutes of Health announced a new $ 17 million program to investigate whether extracellular RNA plays an important signaling role
in people, and whether it can be harnessed to diagnose and treat human diseases, Mitch Leslie reports in News & Analysi
in people, and whether it can be harnessed to diagnose and treat
human diseases, Mitch Leslie
reports in News & Analysi
in News & Analysis.
The journal provides cutting - edge research including results from animal models that are likely to apply to patients, studies
in human tissue that provide new information about therapies or
disease, and innovative
reports of drug discovery and development.
Scientists
report that domestic pigs harbor Reston ebolavirus, the only Ebola species that has not caused
disease in humans
The finding,
reported in next month's issue of Nature Medicine, raises new questions about whether people could contract exotic
diseases if animal organs become routinely transplanted into
human patients.
«We're part of medicine now,» Leslie Biesecker, chief of the Genetic
Disease Research Branch at the National
Human Genome Research Institute
in Bethesda, Maryland, and co-chair of the ACMG working group that wrote the
report, told Science at the time.
«We're part of medicine now,» Leslie Biesecker, chief of the Genetic
Disease Research Branch at the National
Human Genome Research Institute
in Bethesda, Maryland, and co-chair of the ACMG working group that wrote the
report, told
Concerns have been stirred by
reports of research
in China to correct
disease - causing genetic mutations
in non-viable embryos
in 2015 and the granting, by the
Human Fertilisation and Embryology Authority (HFEA), of a licence to allow genome editing of embryos
in the UK February 2016.
Poor Maria also harbored
human papillomavirus
in a venereal wart — the first diagnosis of this sexually transmitted, cancer - causing
disease in the tissue of a mummy, Fornaciari
reported in a 2006 paper.
It was eggshell thinning that devastated fish - eating birds and birds of prey, says Fry, and this effect is well documented
in a
report (pdf) on DDT published
in 2002 by the Department of Health and
Human Services» Agency for Toxic Substances and
Disease Registry (ATSDR).
The method,
reported in the November issue of Nature Biotechnology, could lead to safe and effective
human gene therapies for cystic fibrosis, hemophilia, and a variety of other
diseases.
«Using a technique developed by our collaborators at the University of Iowa, we were able to get long - term expression of these
human gene variants
in the fluid that bathes the entire brain,» says Bradley Hyman, MD, PhD, of the MassGeneral Institute for Neurodegenerative
Disease (MGH - MIND), senior author of the
report in the Nov. 20 Science Translational Medicine.
In such a scenario, disease risk to humans would rise 10-fold, the team reports in a preprint posted this week to bioRxi
In such a scenario,
disease risk to
humans would rise 10-fold, the team
reports in a preprint posted this week to bioRxi
in a preprint posted this week to bioRxiv.
Mouse embryonic stem cells,
reported in 1981 by Martin Evans, Matthew Kaufman, and Gail Martin, have allowed scientists to generate genetically customized strains of mice that have revolutionized studies of organismic development and immunity and have provided countless models of
human disease.
In a novel animal study design that mimicked human clinical trials, researchers at University of California, San Diego School of Medicine report that long - term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's disease (AD) neuropathology and prevents onset of cognitive impairment in a mouse model of the neurodegenerative conditio
In a novel animal study design that mimicked
human clinical trials, researchers at University of California, San Diego School of Medicine
report that long - term treatment using a small molecule drug that reduces activity of the brain's stress circuitry significantly reduces Alzheimer's
disease (AD) neuropathology and prevents onset of cognitive impairment
in a mouse model of the neurodegenerative conditio
in a mouse model of the neurodegenerative condition.
So far there have been no
reports of Parkinson's
disease in human survivors of the H5N1 flu, Smeyne says, but because only a few years have passed since the first cases were
reported, it's too early to know whether those infected are at increased risk.
Their findings,
reported in Nature Communications, may shed light on
human lung
disease,
in particular, the mechanism behind non-familial pulmonary hypertension
in patients with conditions such as emphysema and pulmonary fibrosis.
Researchers
report in Nature today that they have perfected a way to manufacture monoclonal antibodies capable of destroying
diseases such the avian flu, which have the ability to swap genes with
human flu varieties and jump from birds to people.
Dartmouth researchers developed a new biological pathway - based computational model, called the Pathway - based
Human Phenotype Network (PHPN), to identify underlying genetic connections between different
diseases as
reported in BioDataMining this week.
A computational tool developed at the University of Utah (U of U) has successfully identified
diseases with unknown gene mutations
in three separate cases, U of U researchers and their colleagues
report in a new study
in The American Journal of
Human Genetics.
Working with mouse, fly and
human cells and tissue, Johns Hopkins researchers
report new evidence that disruptions
in the movement of cellular materials
in and out of a cell's control center — the nucleus — appear to be a direct cause of brain cell death
in Huntington's
disease, an inherited adult neurodegenerative disorder.
After Liu's initial
report, a group
in China used DNA base editing to correct a
disease - causing mutation
in human embryos cloned from a patient with a genetic blood disorder.
«Although many
reports have addressed the effect of lactic acid bacteria on skin properties
in subjects with skin
diseases, such as atopic dermatitis, few studies have involved healthy
humans,» explains lead investigator Hiromi Kimoto - Nira, PhD, of the National Agriculture and Food Research Organization (NARO) Institute of Livestock and Grassland Science (NILGS), Tsukuba, Japan.
They searched through 60 years of scientific and newspaper
reports to determine two things: first, whether the pathogens cause visible
disease symptoms or death
in wildlife, and second, whether
human outbreaks were preceded or accompanied by evidence of the
disease in animals.
To reduce false positives when identifying genetic variations associated with
human disease through genome - wide association studies (GWAS), Dartmouth researchers have identified nine traits that are not dependent on P values to predict single nucleotide polymorphisms (SNP) reproducibility as reported in Human Genetics on October 2,
human disease through genome - wide association studies (GWAS), Dartmouth researchers have identified nine traits that are not dependent on P values to predict single nucleotide polymorphisms (SNP) reproducibility as
reported in Human Genetics on October 2,
Human Genetics on October 2, 2014.
The finding, by researchers at the University of Illinois at Chicago College of Medicine, was
reported July 16 at the Alzheimer's Association International Conference
in Copenhagen by Mary Jo LaDu, who
in 2012 developed a transgenic mouse that is now regarded as the best animal model of the
human disease.
The new NIST
human genome RMs increase the ability of DNA sequencing laboratories to be more confident
in their
reporting of true positives, false positives, true negatives and false negatives, and therefore, significantly improve genetic tests used for
disease risk prediction, diagnosis, and progression tracking.
The study,
reported here at a
Human Origins and
Disease conference, will appear
in an upcoming issue of
Human Genetics.
From this research published
in Scientific
Reports, scientists aim to unravel the causes behind the
disease in zebrafish and therefore provide new leads for a treatment for
human LCA.
Last November, however, a team led by Mihael Polymeropoulos of the National
Human Genome Research Institute
in Bethesda, Maryland,
reported that the
disease afflicting the Italian family, which develops at an unusually early age, showed strong genetic linkage to a region on chromosome 4.
The test tube finding,
reported in the current Cell, could help explain the formation of prions — the tangled proteins that are implicated
in mad cow
disease and several
human brain disorders — and eventually may lead to a way to smooth out these rogue proteins.
The new flu, known as H7N9 avian influenza, latches onto sugars that coat bird cells — and it can cling to sugars on
human cells too, Yuelong Shu of the China Center for
Disease Control and Prevention and colleagues
report July 3
in Nature.
The Search for Extraterrestrial Intelligence has always looked for an anomaly
in the persistent cosmic background chatter — a change perhaps
in the intensity of a signal that can be taken as a sign that a transmission might be a message to us earthlings from other intelligent beings.Each year, medical researchers who gather at the Alzheimer's Association International Conference search for something similar as they weigh
reports of the complex biology of the
human brain for some sign that a drug might actually change the relentless course of the
disease.
In April 2015, researchers in China reported that they had used CRISPR, with limited success, to repair a disease - causing gene in human embryo
In April 2015, researchers
in China reported that they had used CRISPR, with limited success, to repair a disease - causing gene in human embryo
in China
reported that they had used CRISPR, with limited success, to repair a
disease - causing gene
in human embryo
in human embryos.
Coauthor Niyaz Ahmed, PhD, Professor of Biotechnology & Bioinformatics, University of Hyderabad, India, said that H. pullorum could potentially be pathogenic
in poultry and
in humans, and explained that cases have been
reported of
human enteric
disease caused by this bacterium.
Although mutations had been identified
in other genes important for the recycling of bile acids, this is the first
report in humans of
disease - associated defects
in this gene, called Organic Solute Transporter - beta (SLC51B).
Despite recent successes
in identifying causative mutations for
human heritable
diseases through the use of sequencing technologies, an associated gene has not been identified for approximately half of the
reported diseases.
Blocking a factor that can activate the
human immune response against intestinal bacteria or certain foods could prevent the development of celiac
disease in those most at risk, researchers
report in the journal Nature.
Russell Kern
reports on the 6 - month update on the first -
in -
human clinical study of neural stem cells
in patients with Parkinson's
disease.
JCVI,
in collaboration with UC San Diego, recently completed a
report on «Policy and Regulatory Issues for Gene Drives
in Insects» outlining specific suggestions that could help advance this promising approach for combatting insect - borne
human disease and insect agricultural pests, while ensuring that environmental safety and societal issues are addressed.
PHENOMIN's involvement
in the IMPC will fulfill a key item of the the National Alliance for life sciences and health (AVIESAN) strategic plan that consists
in applying mouse genetics to analyze the mechanisms of
disease and to use this knowledge for advancing fundamental research and
human health (AVIESAN
report on the use and needs of mouse models
in the French scientific community, 2010).
«
In a report published in the journal Lancet, scientists led by Dr. Robert Lanza, chief scientific officer at Advanced Cell Technology, provide the first evidence that stem cells from human embryos can be a safe and effective source of therapies for two types of eye diseases&raqu
In a
report published
in the journal Lancet, scientists led by Dr. Robert Lanza, chief scientific officer at Advanced Cell Technology, provide the first evidence that stem cells from human embryos can be a safe and effective source of therapies for two types of eye diseases&raqu
in the journal Lancet, scientists led by Dr. Robert Lanza, chief scientific officer at Advanced Cell Technology, provide the first evidence that stem cells from
human embryos can be a safe and effective source of therapies for two types of eye
diseases»
Importantly, more that 400 different mutations
in the lamin A gene have been
reported, which are associated with a wide range of
human degenerative
diseases including muscular dystrophy, lipodystrophies and neuropathies.
In a substudy, review outcomes were also compared across different types of clinical research, based in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified human tissu
In a substudy, review outcomes were also compared across different types of clinical research, based
in large part on the designations and definitions derived from a number of sources, including a report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal human behavior); (6) health services research; and (7) use of deidentified human tissu
in large part on the designations and definitions derived from a number of sources, including a
report by Nathan, 14 the Institute of Medicine, 20 the NIH Director's Panel on Clinical Research, 9 the Association of American Medical Colleges and American Medical Association, 21 and the Agency for Healthcare Research and Quality.22 All 3599 R01 applications involving
human subjects that were submitted to NIH for the October 2002 council were categorized into 1 of the following: (1) patient - oriented studies of mechanisms of
human disease (bench to bedside); (2) clinical trials and other clinical interventions; (3) patient - oriented research focusing on development of new technologies; (4) epidemiological studies; (5) behavioral studies (including studies of normal
human behavior); (6) health services research; and (7) use of deidentified
human tissue.